Vaccinating People with Obesity for COVID-19: EASO Call for Action
- PMID: 33915546
- PMCID: PMC8255639
- DOI: 10.1159/000516524
Vaccinating People with Obesity for COVID-19: EASO Call for Action
Keywords: COVID-19; Obesity; Vaccination.
Conflict of interest statement
The authors of this manuscript do not have any conflicts of interest to declare.
Comment on
-
BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting.N Engl J Med. 2021 Apr 15;384(15):1412-1423. doi: 10.1056/NEJMoa2101765. Epub 2021 Feb 24. N Engl J Med. 2021. PMID: 33626250 Free PMC article.
Similar articles
-
BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting.N Engl J Med. 2021 May 20;384(20):1968-1970. doi: 10.1056/NEJMc2104281. Epub 2021 Apr 21. N Engl J Med. 2021. PMID: 33882226 No abstract available.
-
BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting. Reply.N Engl J Med. 2021 May 20;384(20):1970. doi: 10.1056/NEJMc2104281. Epub 2021 Apr 21. N Engl J Med. 2021. PMID: 33882227 No abstract available.
-
Universities as Catalysts for COVID-19 Vaccination: A Call to Action.Health Promot Pract. 2021 Sep;22(5):601-604. doi: 10.1177/15248399211017485. Epub 2021 May 20. Health Promot Pract. 2021. PMID: 34014117
-
SARS-CoV-2 Vaccines.JAMA. 2021 Apr 6;325(13):1318-1320. doi: 10.1001/jama.2021.3199. JAMA. 2021. PMID: 33635317 Review. No abstract available.
-
Applications of telemedicine in the supply and distribution of COVID-19 vaccines in Africa.J Glob Health. 2021 Mar 1;11:03039. doi: 10.7189/jogh.11.03039. J Glob Health. 2021. PMID: 33828830 Free PMC article. Review. No abstract available.
Cited by
-
Association between Overweight/Obesity and the Safety and Efficacy of COVID-19 Vaccination: A Systematic Review.Vaccines (Basel). 2023 May 17;11(5):996. doi: 10.3390/vaccines11050996. Vaccines (Basel). 2023. PMID: 37243100 Free PMC article. Review.
-
Risk Factors Influencing Seroconversion after Inactive SARS-CoV-2 Vaccination in People Living with Obesity.Obes Facts. 2022;15(5):648-654. doi: 10.1159/000525555. Epub 2022 Aug 3. Obes Facts. 2022. PMID: 35921804 Free PMC article.
-
Obesity and its Relationship with Covid-19: A Review of the Main Pharmaceutical Aspects.Curr Pharm Biotechnol. 2024;25(13):1651-1663. doi: 10.2174/0113892010264503231108070917. Curr Pharm Biotechnol. 2024. PMID: 38258769 Review.
-
A Comparative Study of Immunogenicity, Antibody Persistence, and Safety of Three Different COVID-19 Boosters between Individuals with Comorbidities and the Normal Population.Vaccines (Basel). 2023 Aug 17;11(8):1376. doi: 10.3390/vaccines11081376. Vaccines (Basel). 2023. PMID: 37631944 Free PMC article.
-
The effects of obesity and metabolic abnormalities on severe COVID-19-related outcomes after vaccination: A population-based study.Cell Metab. 2023 Apr 4;35(4):585-600.e5. doi: 10.1016/j.cmet.2023.02.016. Epub 2023 Mar 1. Cell Metab. 2023. PMID: 36931274 Free PMC article.
References
-
- Goossens GH, Dicker D, Farpour-Lambert NJ, Frühbeck G, Mullerova D, Woodward E, et al. Obesity and COVID-19: a perspective from the European Association for the Study of Obesity on immunological perturbations, therapeutic challenges, and opportunities in obesity. Obes Facts. 2020;13((4)):439–52. - PMC - PubMed
-
- Simonnet A, Chetboun M, Poissy J, Raverdy V, Noulette J, Duhamel A, et al. LICORN and the Lille COVID-19 and Obesity study group High prevalence of obesity in severe acute respiratory syndrome coronavirus-2 (SARSCoV-2) requiring invasive mechanical ventilation. Obesity (Silver Spring) 2020 Jul;28((7)):1195–9. - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous